Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Suros Surgical Systems logo — Pioneering compassionate, efficient, and minimally invasive...

Suros Surgical Systems

Pioneering compassionate, efficient, and minimally invasive tissue excision and biopsy for improved patient care and clinical outcomes.

Founded 2000 Series Unknown Total: $12.00M Biotechnology, Health Care +2

General Information

Company Name Suros Surgical Systems
Founded Year 2000
Industries Biotechnology, Health Care, Medical Devices +1
Funding Stage Series Unknown
Social

Get notified when Suros Surgical Systems moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Suros Surgical Systems

Suros Surgical Systems is an Indiana-based medical device manufacturer specializing in minimally invasive tissue excision and biopsy technology. Their flagship product, the patented ATEC™ (Automated Tissue Excision and Collection) breast biopsy and excision system, has revolutionized vacuum-assisted diagnostic breast biopsy, offering early diagnosis opportunities for high-risk women. The company's commitment to a minimally invasive approach ensures patients receive top-notch care, with the ATEC™ system delivering substantial improvements in speed, reliability, clinical capabilities, safety, economic efficiency, and ease of use. In August 2004, the company secured a $12.00M Venture Round investment from notable investors including River Cities Capital Funds, Twilight Venture Partners, Rose-Hulman Ventures, Piper Jaffray, and Morgan Stanley Expansion Capital. Suros continues to lead the way in developing new capabilities for minimally invasive tissue excision, making significant strides in the field of biotechnology, healthcare, medical devices, and robotics.

Taxonomy: medical device manufacturer, minimally invasive surgery, biopsy technology, tissue excision, MRI-guided biopsy, breast biopsy system, innovative medical technology, clinical advancements, imaging modality, surgical specialties, compassionate healthcare, outpatient procedures, clinical outcomes, surgical innovations

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 5
Investor Investor Investor
•••• •••• 		18 Aug 2004

Suros Surgical Systems Alternatives & Competitors

Suros Surgical Systems vs
CryoCor
CryoCor

Harnessing the power of cryogenics to restore normal heart function with precision and care.

Series D
Health Care, Manufacturing

FAQ About Suros Surgical Systems

Pioneering compassionate, efficient, and minimally invasive tissue excision and biopsy for improved patient care and clinical outcomes.
Suros Surgical Systems was founded in 2000.
Suros Surgical Systems operates in the following industries: Biotechnology, Health Care, Medical Devices, Robotics.
Suros Surgical Systems has completed 1 funding round, raising a total of $12.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Suros Surgical Systems include CryoCor. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Suros Surgical Systems and CryoCor are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Suros Surgical Systems and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes